NIPT explained

NIPT stands for non-invasive prenatal testing — a screening blood test offered in pregnancy that checks the chance of your baby having certain chromosomal conditions. It’s become a popular option in Australia, and understanding what it is (and isn’t) helps you decide whether it’s right for you.

How it works. During pregnancy, small fragments of your baby’s DNA (from the placenta) circulate in your bloodstream. NIPT analyses a sample of your blood to look at that DNA, which is why it’s called “non-invasive” — it’s just a blood test, with no risk to your pregnancy. It can usually be done from about 10 weeks onwards.

What it screens for. NIPT most commonly checks the chance of the three most common chromosomal conditions: Down syndrome (trisomy 21), and the rarer trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome). Many tests can also tell you your baby’s sex, and some offer screening for other conditions — the options vary by provider, so ask what’s included.

It’s a screening test, not a diagnosis. This is the most important thing to understand. NIPT is very accurate as a screening test — better at picking up Down syndrome than the older combined first-trimester screening — but a “high chance” or “increased risk” result does not mean your baby definitely has the condition. It means a diagnostic test (like CVS or amniocentesis, which take a sample from the placenta or the fluid around the baby) would be offered to confirm or rule it out. A “low chance” result is very reassuring but not an absolute guarantee. Your doctor or a genetic counsellor can explain what your specific result means.

It’s completely optional. Screening is a personal choice, and there’s no right or wrong answer. Some people want as much information as possible; others prefer not to test, or would rather not face decisions based on a probability. It’s worth thinking about, before you have it, what you would do with the information — and knowing that whatever you’d choose is valid. Your GP, midwife or a genetic counsellor can help you think it through.

Cost and practicalities. In Australia, NIPT is usually a private test with an out-of-pocket cost (often somewhere around $400–$600, though it varies), and it’s not generally covered by Medicare — so it’s worth asking about the price when you decide. It’s a simple blood draw, and results usually take a week or two. Occasionally the test can’t get a clear result (a “no call”), and you may be offered a repeat.

How it fits with other screening. NIPT is one option; the other is the combined first-trimester screening (the nuchal translucency scan plus a blood test), which is Medicare-rebatable. You don’t necessarily need both, and your provider can help you choose. Whichever you consider — or if you decide to have no screening at all — the morphology scan around 20 weeks is a separate, routine check that still goes ahead.

A couple of extra points. Occasionally NIPT returns a “no result” (or “no call”) — often simply because there wasn’t enough of your baby’s DNA in the sample yet, which is more common if you’re earlier along or have a higher body weight; you’ll usually be offered a repeat. And while NIPT is very accurate, it isn’t perfect, and it screens for specific conditions rather than everything — it won’t detect many other issues, which is partly why the 20-week morphology scan still matters. If a result raises questions, a genetic counsellor is a brilliant, non-judgemental resource to help you understand it and your options.

The bottom line: NIPT is a safe, accurate screening blood test that can give you early information about your baby’s chance of certain conditions — but it’s optional, it’s not a diagnosis on its own, and it’s worth an informed conversation with your care team about whether, and what, to test.